Pharma Elaine Chen STAT Plus: Our expensive obesity drugs are worth it, Novo Nordisk and Eli Lilly argue in raft of studies
Exclusive Megan Molteni STAT Plus: How one scientist’s determination made Novo Nordisk an obesity-drug powerhouse
Health Nicholas Florko STAT Plus: White House moves closer to a ban on menthol cigarettes, amid intensifying opposition from tobacco companies
Pharmalot Ed Silverman STAT Plus: Teva sues Colorado over ‘unconstitutional’ program to lower cost of epinephrine injectors
Health Elizabeth Cooney Serotonin levels are depleted in long Covid patients, study says, pointing to a potential cause for ‘brain fog’
Biotech Jonathan Wosen STAT Plus: Cell and gene therapy CEOs share survival strategies amid biotech slump
Health Tech Lizzy Lawrence STAT Plus: FDA’s warning to J&J’s Abiomed signals a crackdown on digital health tools
Business Jessica Bartlett — Boston Globe STAT Plus: Dana-Farber’s divorce from Brigham is the culmination of decades of change
First Opinion Leonard Rubenstein Why Gaza health care facilities and workers have suffered so much violence
Pharmalot Ed Silverman STAT Plus: Eye docs urge Medicare to lower insurance hurdles amid shortage of repackaged Avastin
Insurance Bob Herman STAT Plus: UnitedHealth’s profit jumps as medical costs come in lower than expected
Politics Sarah Owermohle STAT Plus: HHS dispatches millions to next-generation Covid targets, including intranasal vaccine
Biotech Andrew Joseph STAT Plus: European regulators once again recommend Amylyx’s ALS drug be rejected
In the Lab Anika Nayak He was named a MacArthur ‘genius’ fellow for research on gene regulation, but still has imposter syndrome
In the Lab Angus Chen STAT Plus: Like a vampire, some cancer cells can suck the energy source from immune cells
The Readout LOUD Damian Garde, Allison DeAngelis and Adam Feuerstein Listen: Merger Mondays, Ozempic panic, & CRISPR’d pigs